JP Morgan Chase’s Immune Design Corp. IMDZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-286,375
| Closed | -$1.68M | – | 6222 |
|
|
2019
Q1 | $1.68M | Sell |
286,375
-242,589
| -46% | -$826K | ﹤0.01% | 3452 |
|
|
2018
Q4 | $687K | Buy |
528,964
+126,058
| +31% | +$219K | ﹤0.01% | 3962 |
|
|
2018
Q3 | $1.39M | Sell |
402,906
-4,938
| -1% | -$18.5K | ﹤0.01% | 3706 |
|
|
2018
Q2 | $1.86M | Sell |
407,844
-435,083
| -52% | -$1.73M | ﹤0.01% | 3470 |
|
|
2018
Q1 | $2.78M | Sell |
842,927
-73,662
| -8% | -$261K | ﹤0.01% | 3039 |
|
|
2017
Q4 | $3.58M | Buy |
916,589
+411,914
| +82% | +$2.24M | ﹤0.01% | 2943 |
|
|
2017
Q3 | $5.42M | Sell |
504,675
-26,027
| -5% | -$256K | ﹤0.01% | 2512 |
|
|
2017
Q2 | $5.17M | Buy |
530,702
+288,009
| +119% | +$2.02M | ﹤0.01% | 2447 |
|
|
2017
Q1 | $1.65M | Sell |
242,693
-29,051
| -11% | -$168K | ﹤0.01% | 3153 |
|
|
2016
Q4 | $1.5M | Sell |
271,744
-58
| -0% | -$410 | ﹤0.01% | 3250 |
|
|
2016
Q3 | $2.06M | Buy |
271,802
+25,127
| +10% | +$184K | ﹤0.01% | 2788 |
|
|
2016
Q2 | $2.01M | Buy |
246,675
+103,750
| +73% | +$1.29M | ﹤0.01% | 2803 |
|
|
2016
Q1 | $1.86M | Buy |
142,925
+2,325
| +2% | +$26.8K | ﹤0.01% | 2742 |
|
|
2015
Q4 | $2.82M | Sell |
140,600
-11,825
| -8% | -$204K | ﹤0.01% | 2571 |
|
|
2015
Q3 | $1.86M | Sell |
152,425
-12,659
| -8% | -$237K | ﹤0.01% | 2783 |
|
|
2015
Q2 | $3.41M | Sell |
165,084
-38,466
| -19% | -$909K | ﹤0.01% | 2621 |
|
|
2015
Q1 | $4.3M | Sell |
203,550
-25,900
| -11% | -$676K | ﹤0.01% | 2455 |
|
|
2014
Q4 | $7.06M | Sell |
229,450
-42,368
| -16% | -$1.18M | ﹤0.01% | 2180 |
|
|
2014
Q3 | $4.8M | Buy |
+271,818
| New | +$3.44M | ﹤0.01% | 2395 |
|
JP Morgan Chase's IMDZ Position: Q2 2019 in Review
JP Morgan Chase sold out of Immune Design Corp. (IMDZ) in Q2 2019, closing a stake of 286,375 shares — an estimated $1.68M sold.
JP Morgan Chase first reported a position in IMDZ in Q3 2014 and held it in 19 quarters. The position peaked at $7.06M in Q4 2014. 0 funds tracked by Wall St. Rank hold IMDZ as of Q2 2019.
- JP Morgan Chase reported no remaining Immune Design Corp. position as of Q2 2019 after selling out during the quarter.
- JP Morgan Chase sold 286,375 Immune Design Corp. shares in Q2 2019, an estimated $1.68M.
- JP Morgan Chase first reported a position in Immune Design Corp. in Q3 2014 and held it in 19 quarters.
- JP Morgan Chase's Immune Design Corp. position peaked at $7.06M in Q4 2014.
- 0 funds tracked by Wall St. Rank held Immune Design Corp. as of Q2 2019.
Based on JP Morgan Chase's 13F filing for Q2 2019, filed 7 Aug 2019.